Publications by authors named "Csaba Farsang"

Claim this Profile
E
Effect of single-pill versus free equivalent combinations on persistence and major adverse cardiovascular events in hypertension: a real-world analysis.
Gábor Simonyi, Michel Burnier, Krzysztof Narkiewicz, György Rokszin, Zsolt Abonyi-Tóth, Csaba Farsang

J Hypertens· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of office blood pressure measurements and the seasonal variability of blood pressure: results of the Hungarian Hypertension Registry.
János Nemcsik, Johanna Takács, Dorottya Pásztor, Csaba Farsang, Attila Simon

Blood Press· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
White-coat effect and masked hypertension in patients with high-normal office blood pressure: results of the Hungarian ABPM Registry.
János Nemcsik, Johanna Takács, Zsófia Kekk, Csaba Farsang, Attila Simon

J Hypertens· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beneficial Effects of a Perindopril/Indapamide Single-Pill Combination in Hypertensive Patients with Diabetes and/or Obesity or Metabolic Syndrome: A Post Hoc Pooled Analysis of Four Observational Studies.
Csaba Farsang, Csaba Andras Dézsi, Romualda Brzozowska-Villatte, Martine De Champvallins, Maria Glezer

Adv Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Perindopril/Indapamide Single-Pill Combination in Uncontrolled Patients with Hypertension: A Pooled Analysis of the FORTISSIMO, FORSAGE, ACES and PICASSO Observational Studies.
Csaba András Dézsi, Maria Glezer, Yuri Karpov, Romualda Brzozowska-Villatte, Csaba Farsang

Adv Ther· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prof. Dr. István Kiss (1952-2018)].
Csaba Farsang

Orv Hetil· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Tolerability of Fixed-Dose Combination Perindopril/Indapamide in Hypertensive Patients with a History of Stroke or Transient Ischemic Attack: PICASSO Trial.
Csaba András Dézsi, Csaba Farsang,

Adv Ther· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The potential role of oscillometric devices for ankle-brachial index measurements in clinical practice].
Zoltán Járai, Endre Kolossváry, Ildikó Szabó, István Kiss, Csaba Farsang

Orv Hetil· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence.
Gábor Simonyi, Tamás Ferenci, Sándor Alföldi, Csaba Farsang

J Int Med Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease: An International Verapamil SR-Trandolapril Ambulatory Monitoring Substudy.
Scott J Denardo, Yan Gong, Rhonda M Cooper-DeHoff, Csaba Farsang, Matyas Keltai

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy.
Scott J Denardo, Yan Gong, Rhonda M Cooper-DeHoff, Csaba Farsang, Matyas Keltai

PLoS One· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.
Alberto Zanchetti, Lisheng Liu, Giuseppe Mancia, Gianfranco Parati, Guido Grassi, Csaba Farsang

J Hypertens· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized evaluation of a novel, fixed-dose combination of perindopril 3.5 mg/amlodipine 2.5 mg as a first-step treatment in hypertension.
Stéphane Laurent, Gianfranco Parati, Irina Chazova, Yuriy Sirenko, Andrejs Erglis, Csaba Farsang

J Hypertens· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence.
Alberto Zanchetti, Lisheng Liu, Giuseppe Mancia, Gianfranco Parati, Guido Grassi, Csaba Farsang

J Hypertens· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial.
Alberto Zanchetti, Lisheng Liu, Giuseppe Mancia, Gianfranco Parati, Guido Grassi, Csaba Farsang

J Hypertens· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of fixed-dose combination of perindopril/indapamide in type 2 diabetes mellitus: PICASSO trial.
Csaba Farsang

Adv Ther· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure and metabolic efficacy of fixed-dose combination of perindopril and indapamide in everyday practice.
Csaba Farsang,

Blood Press· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz, Josep Redon, Alberto Zanchetti, Csaba Farsang

Eur Heart J· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-density lipoprotein cholesterol and high-sensitivity C-reactive protein lowering with atorvastatin in patients of South Asian compared with European origin: insights from the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) study.
Milan Gupta, Pierre Martineau, Thang Tran, Jean-Pierre Després, Allan Gaw, Csaba Farsang

J Clin Pharmacol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk.
Csaba Farsang

Vasc Health Risk Manag· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study.
Guido Grassi, Renata Cifkova, Stephane Laurent, Krzysztof Narkiewicz, Joseph Redon, Csaba Farsang

Eur Heart J· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.
Giuseppe Mancia, Stéphane Laurent, Enrico Agabiti-Rosei, Ettore Ambrosioni, Michel Burnier, Csaba Farsang

Blood Press· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.
Giuseppe Mancia, Stéphane Laurent, Enrico Agabiti-Rosei, Ettore Ambrosioni, Michel Burnier, Csaba Farsang

J Hypertens· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure control and components of the metabolic syndrome: the GOOD survey.
Walter Zidek, Lisa Naditch-Brûlé, Stefano Perlini, Csaba Farsang, Sverre E Kjeldsen

Cardiovasc Diabetol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Where are we with the management of hypertension? From science to clinical practice.
Csaba Farsang, Lisa Naditch-Brule, Angelo Avogaro, Jan Ostergren, Paolo Verdecchia

J Clin Hypertens (Greenwich)· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis